Maven Securities LTD Axsome Therapeutics, Inc. Transaction History

Maven Securities LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	SELL	$69.25 - $82.21 $1.9 Million - $2.26 Million	-27,500 Reduced 78.57%	7,500 $524,000
Q2 2023 Aug 04, 2023	BUY	$58.41 - $90.35 $2.04 Million - $3.16 Million	35,000 New	35,000 $2.52 Million
Q1 2022 May 16, 2022	SELL	$23.7 - $41.39 $403,302 - $704,333	-17,017 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$30.7 - $43.36 $522,421 - $737,857	17,017 New	17,017 $643,000
Q3 2021 Nov 15, 2021	SELL	$19.91 - $68.26 $548,480 - $1.88 Million	-27,548 Closed	0 $0

Q2 2021 Aug 16, 2021	BUY	$50.63 - $73.5 $1.39 Million - $2.02 Million	27,548 New	27,548 $1.94 Million

290

37.1M

401K

464K

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $3.44B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.